Leukaemia 'firsts' in cancer research and treatment (original) (raw)

• Greaves, M. Cancer: The Evolutionary Legacy (Oxford Univ. Press, 2000).
  Google Scholar
• Wright, N. A. Boveri at 100: cancer evolution, from preneoplasia to malignancy. J. Pathol. 234, 146–151 (2014).
  PubMed Google Scholar
• Heim, S. & Mitelman, F. Cancer Cytogenetics (Alan R. Liss, 1987).
  Google Scholar
• Nowell, P. & Hungerford, D. A minute chromosome in human granulocytic leukemia. Science 132, 1497 (1960).
  Google Scholar
• Rowley, J. D. Chromosome translocations: dangerous liaisons revisited. Nat. Rev. Cancer 1, 245–250 (2001).
  Article CAS PubMed Google Scholar
• Heisterkamp, N. et al. Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature 306, 239–242 (1983).
  Article CAS PubMed Google Scholar
• Konopka, J. B., Watanabe, S. M. & Witte, O. N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37, 1035–1042 (1984).
  Article CAS PubMed Google Scholar
• Mertens, F., Johansson, B., Fioretos, T. & Mitelman, F. The emerging complexity of gene fusions in cancer. Nat. Rev. Cancer 15, 371–381 (2015).
  Article CAS PubMed Google Scholar
• Dalla-Favera, R. et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA 79, 7824–7827 (1982).
  Article CAS PubMed PubMed Central Google Scholar
• Taub, R. et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl Acad. Sci. USA 79, 7837–7841 (1982).
  Article CAS PubMed PubMed Central Google Scholar
• Cleary, M. L. & Sklar, J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA 82, 7439–7443 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. & Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229, 1390–1393 (1985).
  Article CAS PubMed Google Scholar
• Küppers, R. & Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580–5594 (2001).
  Article PubMed Google Scholar
• Cory, S. & Adams, J. M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647–656 (2002).
  Article CAS PubMed Google Scholar
• Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–537 (1999).
  Article CAS PubMed Google Scholar
• Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758–764 (2007).
  Article CAS PubMed Google Scholar
• Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66–72 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Fialkow, P. J. The origin and development of human tumors studied with cell markers. N. Engl. J. Med. 291, 26–35 (1974).
  Article CAS PubMed Google Scholar
• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
  Article CAS PubMed Google Scholar
• Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Anderson, K. et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469, 356–361 (2011).
  Article CAS PubMed Google Scholar
• Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–278 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Klco, J. M. et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell 25, 379–392 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Schuh, A. et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120, 4191–4196 (2012).
  Article CAS PubMed Google Scholar
• Egan, J. B. et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood 120, 1060–1066 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225–233 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751–759 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110, 4009–4014 (2013).
  Article PubMed PubMed Central Google Scholar
• Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353–357 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Boutros, P. C. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47, 736–745 (2015).
  Article CAS PubMed Google Scholar
• Potter, N. E. et al. Single-cell mutational profiling and clonal phylogeny in cancer. Genome Res. 23, 2115–2125 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Navin, N. E. Cancer genomics: one cell at a time. Genome Biol. 15, 452 (2014).
  Article PubMed PubMed Central Google Scholar
• Eirew, P. et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 518, 422–426 (2015).
  Article CAS PubMed Google Scholar
• Yates, L. R. & Campbell, P. J. Evolution of the cancer genome. Nat. Rev. Genet. 13, 795–806 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mullighan, C. G. et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322, 1377–1380 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, Y. et al. Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas. Genome Biol. 15, 432 (2014).
  PubMed PubMed Central Google Scholar
• Juric, D. et al. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor. Nature 518, 240–244 (2015).
  Article CAS PubMed Google Scholar
• Marshall, G. M. et al. The prenatal origins of cancer. Nat. Rev. Cancer 14, 277–289 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nat. Rev. Cancer 3, 639–649 (2003).
  Article CAS PubMed Google Scholar
• Greaves, M. F., Maia, A. T., Wiemels, J. L. & Ford, A. M. Leukemia in twins: lessons in natural history. Blood 102, 2321–2333 (2003).
  Article CAS PubMed Google Scholar
• Wiemels, J. L. et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354, 1499–1503 (1999).
  Article CAS PubMed Google Scholar
• Mori, H. et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl Acad. Sci. USA 99, 8242–8247 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Strong, S. J. & Corney, G. The Placenta in Twin Pregnancy (Pergamon Press, 1967).
  Google Scholar
• Ma, Y. et al. Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 110, 7429–7433 (2013).
  Article PubMed PubMed Central Google Scholar
• Cazzaniga, G. et al. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood 118, 5559–5565 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bateman, C. M. et al. Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia. Blood 115, 3553–3558 (2010).
  Article CAS PubMed Google Scholar
• Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Shlush, L. I. et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506, 328–333 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Corces-Zimmerman, M. R. & Majeti, R. Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis. Leukemia 28, 2276–2282 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, X. et al. Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse. Leukemia 28, 1751–1754 (2014).
  Article CAS PubMed Google Scholar
• Ford, A. M. et al. Protracted dormancy of pre-leukaemic stem cells. Leukemia 29, 2202–2207 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Greaves, M. Does everyone develop covert cancer? Nat. Rev. Cancer 14, 209–210 (2014).
  Article CAS PubMed Google Scholar
• Martincorena, I. et al. Tumor evolution: high burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Aparicio, S. & Caldas, C. The implications of clonal genome evolution for cancer medicine. N. Engl. J. Med. 368, 842–851 (2013).
  Article CAS PubMed Google Scholar
• Greaves, M. Evolutionary determinants of cancer. Cancer Discov. 5, 806–820 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Kreso, A. & Dick, J. E. Evolution of the cancer stem cell model. Cell Stem Cell 14, 275–291 (2014).
  Article CAS PubMed Google Scholar
• Yap, T. A., Gerlinger, M., Futreal, P. A., Pusztai, L. & Swanton, C. Intratumor heterogeneity: seeing the wood for the trees. Sci. Transl Med. 4, 127ps10 (2012).
  Article CAS PubMed Google Scholar
• McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27, 15–26 (2015).
  Article CAS PubMed Google Scholar
• Polak, P. et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518, 360–364 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Visvader, J. E. Cells of origin in cancer. Nature 469, 314–322 (2011).
  Article CAS PubMed Google Scholar
• Pierce, G. B., Shikes, R. & Fink, L. M. Cancer: A Problem of Developmental Biology (Prentice Hall Inc., 1978).
  Google Scholar
• Fialkow, P. J., Denman, A. M., Jacobson, R. J. & Lowenthal, M. N. Chronic myelocytic leukemia: origin of some lymphocytes from leukemic stem cells. J. Clin. Invest. 62, 815–823 (1978).
  Article CAS PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Sachs, L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 274, 535–539 (1978).
  Article CAS PubMed Google Scholar
• Beug, H., Hayman, M. J. & Graf, T. Leukaemia as a disease of differentiation: retroviruses causing acute leukaemias in chickens. Cancer Surveys 1, 205–230 (1982).
  Google Scholar
• Greaves, M. F. Differentiation-linked leukaemogenesis in lymphocytes. Science 234, 697–704 (1986).
  Article CAS PubMed Google Scholar
• Küppers, R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251–262 (2005).
  Article CAS PubMed Google Scholar
• Zhu, Y. & Parada, L. F. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer 2, 616–626 (2002).
  Article CAS PubMed Google Scholar
• Gibson, P. et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 468, 1095–1099 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Alcantara Llaguno, S. R. et al. Adult lineage-restricted CNS progenitors specify distinct glioblastoma subtypes. Cancer Cell 28, 429–440 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Greaves, M. in Nathan and Oski's Hematology and Oncology of Infancy and Childhood (eds Orkin, S. H. et al.) 1229–1238 (Elsevier Saunders, 2015).
  Google Scholar
• Paugh, B. S. et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J. Clin. Oncol. 28, 3061–3068 (2010).
  Article PubMed PubMed Central Google Scholar
• Filbin, M. G. & Stiles, C. D. Of brains and blood: developmental origins of glioma diversity? Cancer Cell 28, 403–404 (2015).
  Article CAS PubMed Google Scholar
• Huntly, B. J. & Gilliland, D. G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 5, 311–321 (2005).
  Article CAS PubMed Google Scholar
• Dick, J. E. Stem cell concepts renew cancer research. Blood 112, 4793–4807 (2008).
  Article CAS PubMed Google Scholar
• Rosen, J. M. & Jordan, C. T. The increasing complexity of the cancer stem cell paradigm. Science 324, 1670–1673 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283–296 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593–598 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gentles, A. J., Plevritis, S. K., Majeti, R. & Alizadeh, A. A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304, 2706–2715 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086–1093 (2011).
  Article CAS PubMed Google Scholar
• Hartwell, K. A. et al. Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nat. Chem. Biol. 9, 840–848 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Notta, F. et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469, 362–367 (2011).
  Article CAS PubMed Google Scholar
• Piccirillo, S. G. M. et al. Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Rep. 4, 7–15 (2015).
  Article CAS Google Scholar
• Meyer, M. et al. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proc. Natl Acad. Sci. USA 112, 851–856 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Greaves, M. Cancer stem cells as 'units of selection'. Evol. Appl. 6, 102–108 (2013).
  Article PubMed Google Scholar
• Fong, C. Y. et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature 525, 538–542 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Greaves, M. F. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res. 41, 4752–4766 (1981).
  CAS PubMed Google Scholar
• Chessells, J. M., Hardisty, R. M., Rapson, N. T. & Greaves, M. F. Acute lymphoblastic leukaemia in children: classification and prognosis. Lancet ii, 1307–1309 (1977).
• Sallan, S. E. et al. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. Blood 55, 395–402 (1980).
  CAS PubMed Google Scholar
• Greaves, M. F., Janossy, G., Peto, J. & Kay, H. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br. J. Haematol. 48, 179–197 (1981).
  Article CAS PubMed Google Scholar
• Swerdlow, S. H. et al. (eds) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (IARC, 2008).
  Google Scholar
• Pui, C.-H., Relling, M. V. & Downing, J. R. Acute lymphoblastic leukemia. N. Engl. J. Med. 350, 1535–1548 (2004).
  Article CAS PubMed Google Scholar
• Armstrong, S. A. & Look, A. T. Molecular genetics of acute lymphoblastic leukemia. J. Clin. Oncol. 23, 6306–6315 (2005).
  Article CAS PubMed Google Scholar
• Hunger, S. P. & Mullighan, C. G. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood 125, 3977–3987 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619–625 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465–472 (2012).
  Article CAS PubMed Google Scholar
• Maley, C. C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38, 468–473 (2006).
  Article CAS PubMed Google Scholar
• Mroz, E. A. et al. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer 119, 3034–3042 (2013).
  Article PubMed Google Scholar
• Michor, F. et al. Dynamics of chronic myeloid leukaemia. Nature 435, 1267–1270 (2005).
  Article CAS PubMed Google Scholar
• Pinkel, D. in White Blood: Personal Journeys with Childhood Leukaemia (ed. Greaves, M.) 13–46 (World Scientific, 2008).
  Book Google Scholar
• Inaba, H., Greaves, M. & Mullighan, C. G. Acute lymphoblastic leukaemia. Lancet 381, 1943–1955 (2013).
  Article PubMed Google Scholar
• Bhojwani, D. et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia 26, 265–270 (2012).
  Article CAS PubMed Google Scholar
• Newlands, E. S. et al. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979–1984). Br. J. Obstet. Gynaecol. 93, 63–69 (1986).
  Article CAS PubMed Google Scholar
• Horwich, A., Nicol, D. & Huddart, R. Testicular germ cell tumours. BMJ 347, f5526 (2013).
  Article PubMed Google Scholar
• Papaemmanuil, E. et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6–RUNX1 acute lymphoblastic leukemia. Nat. Genet. 46, 116–125 (2014).
  CAS PubMed PubMed Central Google Scholar
• Litchfield, K. et al. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours. Nat. Commun. 6, 5973 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Gutekunst, M. et al. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PLoS ONE 6, e19198 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Al-Lazikani, B., Banerji, U. & Workman, P. Combinatorial drug therapy for cancer in the post-genomic era. Nat. Biotechnol. 30, 679–692 (2012).
  Article CAS PubMed Google Scholar
• Druker, B. J. Perspectives on the development of imatinib and the future of cancer research. Nat. Med. 15, 1149–1152 (2009).
  Article CAS PubMed Google Scholar
• Corbin, A. S. et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest. 121, 396–409 (2011).
  Article CAS PubMed Google Scholar
• Sosa, M. S., Bragado, P. & Aguirre-Ghiso, J. A. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat. Rev. Cancer 14, 611–622 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, B. et al. Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 17, 427–442 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Essers, M. A. & Trumpp, A. Targeting leukemic stem cells by breaking their dormancy. Mol. Oncol. 4, 443–450 (2010).
  Article PubMed PubMed Central Google Scholar
• Roche-Lestienne, C. et al. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. Blood 100, 1014–1018 (2002).
  Article CAS PubMed Google Scholar
• Pfeifer, H. et al. Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood 110, 727–734 (2007).
  Article CAS PubMed Google Scholar
• Shih, A. H., Abdel-Wahab, O., Patel, J. P. & Levine, R. L. The role of mutations in epigenetic regulators in myeloid malignancies. Nat. Rev. Cancer 12, 599–612 (2012).
  Article CAS PubMed Google Scholar
• Lotem, J. & Sachs, L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin. Cancer Biol. 12, 339–346 (2002).
  Article CAS PubMed Google Scholar
• Wang, Z. Y. & Chen, Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111, 2505–2515 (2008).
  Article CAS PubMed Google Scholar
• Zhu, J., Chen, Z., Lallemand-Breitenbach, V. & de The, H. How acute promyelocytic leukaemia revived arsenic. Nat. Rev. Cancer 2, 705–713 (2002).
  Article CAS PubMed Google Scholar
• Ablain, J. et al. Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure. Nat. Med. 20, 167–174 (2014).
  Article CAS PubMed Google Scholar
• Schenk, T. et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-_trans_-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 18, 605–611 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, X., Cruz, F. D., Terry, M., Remotti, F. & Matushansky, I. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene 32, 2249–2260 (2013).
  Article CAS PubMed Google Scholar
• Cruz, F. D. & Matushansky, I. Solid tumor differentiation therapy – is it possible? Oncotarget 3, 559–567 (2012).
  Article PubMed Google Scholar
• Laugesen, A. & Helin, K. Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell 14, 735–751 (2014).
  Article CAS PubMed Google Scholar
• Sykes, S. M. et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146, 697–708 (2011).
  Article CAS PubMed Google Scholar
• Thomas, E. D. Bone marrow transplantation: a review. Semin. Hematol. 36, 95–103 (1999).
  CAS PubMed Google Scholar
• Nivison-Smith, I. et al. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol. Blood Marrow Transplant. 15, 1323–1330 (2009).
  Article PubMed Google Scholar
• Jenq, R. R. & van den Brink, M. R. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat. Rev. Cancer 10, 213–221 (2010).
  Article CAS PubMed Google Scholar
• Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302–312 (2009).
  Article CAS PubMed Google Scholar
• Pietras, W. Advances and changes in the treatment of children with nephroblastoma. Adv. Clin. Exp. Med. 21, 809–820 (2012).
  PubMed Google Scholar
• Necchi, A. et al. High-dose chemotherapy for germ cell tumors: do we have a model? Expert Opin. Biol. Ther. 15, 33–44 (2015).
  Article CAS PubMed Google Scholar
• Sureda, A. et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 50, 1037–1056 (2015).
  Article CAS PubMed Google Scholar
• Demirer, T. et al. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. Nat. Clin. Pract. Oncol. 5, 256–267 (2008).
  Article CAS PubMed Google Scholar
• Bachireddy, P., Burkhardt, U. E., Rajasagi, M. & Wu, C. J. Haematological malignancies: at the forefront of immunotherapeutic innovation. Nat. Rev. Cancer 15, 201–215 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507–1517 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Larson, S. M., Carrasquillo, J. A., Cheung, N. K. & Press, O. W. Radioimmunotherapy of human tumours. Nat. Rev. Cancer 15, 347–360 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P. & Boon, T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14, 135–146 (2014).
  Article CAS PubMed Google Scholar
• Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015).
  Article CAS PubMed Google Scholar
• Weiner, G. J. Building better monoclonal antibody-based therapeutics. Nat. Rev. Cancer 15, 361–370 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Adams, G. P. & Weiner, L. M. Monoclonal antibody therapy of cancer. Nat. Biotechnol. 23, 1147–1157 (2005).
  Article CAS PubMed Google Scholar
• Miller, J. F. & Sadelain, M. The journey from discoveries in fundamental immunology to cancer immunotherapy. Cancer Cell 27, 439–449 (2015).
  Article CAS PubMed Google Scholar
• Reiss, K. A., Forde, P. M. & Brahmer, J. R. Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy. Immunotherapy 6, 459–475 (2014).
  Article CAS PubMed Google Scholar
• Rizvi, N. A. et al. Cancer immunology: mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124–128 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Szczepanski, T., Orfao, A., van der Velden, V. H., San Miguel, J. F. & van Dongen, J. J. Minimal residual disease in leukaemia patients. Lancet Oncol. 2, 409–417 (2001).
  Article CAS PubMed Google Scholar
• van Dongen, J. J. M. et al. Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia. Lancet 352, 1731–1738 (1998).
  Article CAS PubMed Google Scholar
• van Dongen, J. J., van der Velden, V. H., Bruggemann, M. & Orfao, A. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood 125, 3996–4009 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Hourigan, C. S. & Karp, J. E. Minimal residual disease in acute myeloid leukaemia. Nat. Rev. Clin. Oncol. 10, 460–471 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl Med. 6, 224ra24 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Dawson, S. J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199–1209 (2013).
  Article CAS PubMed Google Scholar
• Garcia-Murillas, I. et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci. Transl Med. 7, 302ra133 (2015).
  Article PubMed Google Scholar
• Franceschi, S. & Herrero, R. in IARC World Cancer Report 2014 (eds Stewart, B. W. & Wild, C. P.) 105–114 (IARC, 2014).
  Google Scholar
• Zur Hausen, H. Infections Causing Human Cancer (Wiley-VCH, 2006).
  Book Google Scholar
• Cohen, J. I., Fauci, A. S., Varmus, H. & Nabel, G. J. Epstein-Barr virus: an important vaccine target for cancer prevention. Sci. Transl Med. 3, 107fs7 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878–889 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ellermann, V. & Bang, O. Experimentelle Leukämie bei Hühnern. Zentralbl. Bakteriol. 46, 595 (1908).
  Google Scholar
• Rous, P. A sarcoma of the fowl transmissible by agent separable from tumor cells. J. Exp. Med. 13, 397–411 (1911).
  Article CAS PubMed PubMed Central Google Scholar
• Gross, L. Oncogenic Viruses (Pergamon Press, 1983).
  Google Scholar
• Jarrett, W. F., Crawford, E. M., Martin, W. B. & Davie, F. A. Virus-like particle associated with leukemia (lymphosarcoma). Nature 202, 567–569 (1964).
  Article CAS PubMed Google Scholar
• Hardy, W. D. et al. Horizontal transmission of feline leukaemia virus. Nature 244, 266–269 (1973).
  Article PubMed Google Scholar
• Burny, A. et al. Bovine leukemia virus involvement in enzootic bovine leukosis. Adv. Cancer Res. 28, 251–311 (1978).
  Article CAS PubMed Google Scholar
• Jarrett, W. et al. Vaccination against feline leukaemia virus using a cell membrane antigen system. Int. J. Cancer 16, 134–141 (1975).
  Article CAS PubMed Google Scholar
• Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet i, 702–703 (1964).
  Article Google Scholar
• Gallo, R. C., Essex, M. E. & Gross, L. (eds) Human T-cell Leukemia/Lymphoma Virus: The Family of Human T-Lymphotropic Retroviruses: Their Role in Malignancies and Association with AIDS (Cold Spring Harbor Laboratory Press, 1984).
  Google Scholar
• Matsuoka, M. & Jeang, K. T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7, 270–280 (2007).
  Article CAS PubMed Google Scholar
• Isaacson, P. G. & Du, M.-Q. MALT lymphoma: from morphology to molecules. Nat. Rev. Cancer 4, 644–653 (2004).
  Article CAS PubMed Google Scholar
• Peek, R. M. Jr & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28–37 (2002).
  Article CAS PubMed Google Scholar
• Schulz, M. D. et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514, 508–512 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759–771 (2013).
  Article CAS PubMed Google Scholar
• Cuzick, J. et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 10, 501–507 (2009).
  Article CAS PubMed Google Scholar
• Kostadinov, R. L. et al. NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet. 9, e1003553 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Stewart, B. W. & Wild, C. P. (eds) World Cancer Report 2014 (IARC, 2014).
  Google Scholar
• Medawar, P. B. The Art of the Soluble (Methuen & Co. Ltd, 1967).
  Google Scholar
• Sato, T. & Clevers, H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190–1194 (2013).
  Article CAS PubMed Google Scholar
• Wang, J. C. Y. & Dick, J. E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494–501 (2005).
  Article CAS PubMed Google Scholar
• Metcalf, D. Hematopoietic cytokines. Blood 111, 485–491 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Wyke, J. & Weiss, R. (eds) Cancer Surveys: Viruses in Human and Animal Cancers (Oxford Univ. Press, 1984).
  Google Scholar
• Herzenberg, L. A. et al. The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin. Chem. 48, 1819–1827 (2002).
  CAS PubMed Google Scholar
• Piller, G. Rays of Hope – The Story of the Leukaemia Research Fund (Leukaemia Research Fund, 1994).
  Google Scholar
• Luch, A. Nature and nurture – lessons from chemical carcinogenesis. Nat. Rev. Cancer 5, 113–125 (2005).
  Article CAS PubMed Google Scholar
• Tabin, C. J. et al. Mechanism of activation of a human oncogene. Nature 300, 143–149 (1982).
  Article CAS PubMed Google Scholar
• Reddy, E. P., Reynolds, R. K., Santos, E. & Barbacid, M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300, 149–152 (1982).
  Article CAS PubMed Google Scholar
• Zetter, B. R. The scientific contributions of M. Judah Folkman to cancer research. Nat. Rev. Cancer 8, 647–654 (2008).
  Article CAS PubMed Google Scholar
• Campbell, P. J. et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat. Genet. 40, 722–729 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Fletcher, O. & Houlston, R. S. Architecture of inherited susceptibility to common cancer. Nat. Rev. Cancer 10, 353–361 (2010).
  Article CAS PubMed Google Scholar
• Lenoir, G. M., O'Conor, G. T. & Olweny, C. L. M. (eds) Burkitt's Lymphoma: A Human Cancer Model (WHO/IARC, 1985).
  Google Scholar
• Burkitt, D. P. in Burkitt's Lymphoma: A Human Cancer Model (eds Lenoir, G. M., O'Conor, G. T. & Olwany, C. L. M.) 11–15 (IARC, 1985).
  Google Scholar
• Boshoff, C. & Weiss, R. AIDS-related malignancies. Nat. Rev. Cancer 2, 373–382 (2002).
  Article CAS PubMed Google Scholar
• Young, L. S. & Rickinson, A. B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757–768 (2004).
  Article CAS PubMed Google Scholar
• Laszlo, J. The Cure of Childhood Leukaemia (Rutgers Univ. Press, 1995).
  Google Scholar